Clinical Trials Browser

Interventional × Colonic Neoplasms × envafolimab × Clear all

NCT06014372 2024-04-12

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT05335460 2022-04-19

To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms